Relation of Serum Lipids and Lipoproteins with Progression of CKD

Mahboob Rahman(FIND), Daniel J. Rader(University of Pennsylvania), Louise Strauss(University Hospitals Cleveland Medical Center), Valerie Teal(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lawrence J. Appel(Johns Hopkins University), Arnold Alper(Tulane University), Dominic S. Raj(George Washington University), Jeffrey R. Schelling(Case Western Reserve University), Sanjeev Akkina(University of Illinois Chicago), Amanda H. Anderson(University of Pennsylvania), Jiang He(Southwestern Medical Center), Wei Yang(Kidney Research UK)
Clinical Journal of the American Society of Nephrology
May 16, 2014
10.2215/cjn.09320913
Cited by 186

Related Papers

Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
|Circulation|2005|4k
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
|The Lancet|2021|3.8k
Prevalence of Diabetes among Men and Women in China
|New England Journal of Medicine|2010|3.1k
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
|Nature Genetics|2006|2.3k